NASDAQ: PALI
Palisade Bio Inc Stock Ownership - Who owns Palisade Bio?

Insider buying vs selling

Have Palisade Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Donald Allen WilliamsDirector2024-05-281,000$4.86
$4.86kBuy
John David FinleyCEO CFO Director2024-05-28607$4.76
$2.89kSell
John David FinleyCEO CFO Director2024-05-28959$4.76
$4.56kSell
John David FinleyCEO CFO Director2024-05-28467$4.76
$2.22kSell
Mitchell Lawrence JonesChief Medical Officer2024-05-28461$4.76
$2.19kSell
Mitchell Lawrence JonesChief Medical Officer2024-05-28810$4.76
$3.86kSell
John David FinleyCEO CFO Director2024-05-241,000$4.81
$4.81kBuy
John David FinleyCEO CFO Director2024-05-20666$4.97
$3.31kBuy
John David FinleyCEO CFO Director2024-05-0661$8.46
$516.06Sell
John David FinleyCEO CFO Director2024-05-0667$8.46
$566.82Sell

1 of 2

PALI insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PALI insiders and whales buy or sell their stock.

PALI Shareholders

What type of owners hold Palisade Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Richard Garr45.18%1,986,304$1.43MInsider
Regional Medical Center Yuma41.27%1,814,375$1.31MInsider
Princeton Capital Corp29.43%1,293,814$931.55kInsider
Stanley Westreich27.14%1,193,281$859.16kInsider
Karl Johe21.16%930,373$669.87kInsider
Robert J. Trenschel7.17%315,399$227.09kInsider
Sandford D. Smith5.00%219,916$158.34kInsider
John Conron2.63%115,492$83.15kInsider
Catherine A. Sohn2.43%106,952$77.01kInsider
Armistice Capital LLC2.40%105,367$75.86kInstitution

1 of 3

PALI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PALI2.35%97.65%Net Selling
XRTX8.24%0.00%
EYEN22.55%77.45%Net Buying
GLTO2.08%97.92%Net Selling
TTNP0.01%99.99%

Palisade Bio Stock Ownership FAQ

Who owns Palisade Bio?

Palisade Bio (NASDAQ: PALI) is owned by 4.53% institutional shareholders, 188.03% Palisade Bio insiders, and 0.00% retail investors. Richard Garr is the largest individual Palisade Bio shareholder, owning 1.99M shares representing 45.18% of the company. Richard Garr's Palisade Bio shares are currently valued at $1.41M.

If you're new to stock investing, here's how to buy Palisade Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.